Ultrasound-guided Suprainguinal Fascia Iliaca Compartment Block for Analgesia After Total Hip Arthroplasty
HIPFIB
The Efficacy of Ultrasound-guided Suprainguinal Fascia Iliaca Compartment Block on Early Post-operative Analgesia After Total Hip Arthroplasty
1 other identifier
interventional
133
1 country
1
Brief Summary
Total hip replacement (THR) is a common and major surgical procedure performed in elderly patients with significant comorbidities. Optimizing a patient's anesthetic and analgesic modalities could play a significant role in minimizing the risk of adverse events in the perioperative period and potentially shorten time to discharge and recovery. Establishing a safe and effective post-operative analgesic plan is of central importance to successful THR anesthesia care. The application of ultrasound visualization has improved the efficacy of the fascia iliaca compartment block (FICB). However, ultrasound-guided suprainguinal FICB has not yet been evaluated clinically in a large trial as a method of providing post-operative analgesia following THR. The investigators hypothesize that by performing the suprainguinal fascia iliaca block with ultrasound, it will be possible to achieve superior and more reliable analgesia in the first 24 hours than without a block.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Aug 2018
Typical duration for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 27, 2017
CompletedFirst Posted
Study publicly available on registry
March 3, 2017
CompletedStudy Start
First participant enrolled
August 30, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 27, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2022
CompletedDecember 12, 2023
July 1, 2018
3.7 years
February 27, 2017
December 11, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Opioid Consumption at 24 hours after arrival in post-operative care unit
Opioid consumption at 24 hours after arrival in PACU amongst the various treatment groups will be our primary outcome. Opioid usage for the first 24 hours will be simply determined from the patient-controlled analgesia data in addition to oral narcotics administered.
24 hours
Secondary Outcomes (5)
Pain Scores
Every 4 hours after arrival in post-operative care unit for 24 hours
Respiratory Depression
Every 4 hours after arrival in post-operative care unit for 24 hours
Nausea
Every 4 hours after arrival in post-operative care unit for 24 hours
Vomiting
Every 4 hours after arrival in post-operative care unit for 24 hours
Pruritus
Every 4 hours after arrival in post-operative care unit for 24 hours
Study Arms (2)
0.5% Ropivacaine
ACTIVE COMPARATORUltrasound-guided suprainguinal fascia iliaca compartment block with 40mls 0.5% ropivacaine.
Normal Saline
PLACEBO COMPARATORUltrasound-guided suprainguinal fascia iliaca compartment block with 40mls normal saline.
Interventions
Ultrasound-guided suprainguinal fascia iliaca compartment block with 40mls 0.5% ropivacaine.
Ultrasound-guided suprainguinal fascia iliaca compartment block with 40mls normal saline.
Eligibility Criteria
You may qualify if:
- Patients aged 18-75, ASA I-III scheduled to undergo unilateral total hip arthroplasty.
You may not qualify if:
- Patients not providing informed consent.
- Refusal of treatment plan.
- Pre-existing medical/neurological/hematologic conditions contraindicated for spinal anesthesia or peripheral nerve blocks.
- Revision total hip arthroplasty.
- Known allergy to any of the medications being used.
- History of drug or alcohol abuse.
- Patients with chronic pain on slow-release preparations of opioid in excess of 30mg of morphine equivalence per day.
- Patients with Rheumatoid Arthritis.
- Patients with psychiatric disorders.
- Patients with prior surgery in the inguinal region or inguinal hernia
- Patients unable or unwilling to use Patient Control Analgesia.
- Diabetic patients with diabetic neuropathy or those with impaired renal function (Creatinine \>106).
- Patients with BMI \>45.
- Patients with body weight \<65kg.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Holland Orthopedic and Arthritic Centre
Toronto, Ontario, M2N 3Y7, Canada
Related Publications (1)
Safa B, Trinh H, Lansdown A, McHardy PG, Gollish J, Kiss A, Kaustov L, Choi S. Ultrasound-guided suprainguinal fascia iliaca compartment block and early postoperative analgesia after total hip arthroplasty: a randomised controlled trial. Br J Anaesth. 2024 Jul;133(1):146-151. doi: 10.1016/j.bja.2024.04.019. Epub 2024 May 18.
PMID: 38762396DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 27, 2017
First Posted
March 3, 2017
Study Start
August 30, 2018
Primary Completion
April 27, 2022
Study Completion
May 1, 2022
Last Updated
December 12, 2023
Record last verified: 2018-07